![HIV Pre-exposure Prophylaxis (PrEP) Care System | Prevent | Effective Interventions | HIV/AIDS | CDC HIV Pre-exposure Prophylaxis (PrEP) Care System | Prevent | Effective Interventions | HIV/AIDS | CDC](https://www.cdc.gov/hiv/images/effective-interventions/prevent/prep/cdc-hiv-continuum-of-PrEP-care.png)
HIV Pre-exposure Prophylaxis (PrEP) Care System | Prevent | Effective Interventions | HIV/AIDS | CDC
![First Participant Infused with Potential HIV Cure Enters Phase 1 Clinical Trials via American Gene Technologies AGT103-T · BioBuzz First Participant Infused with Potential HIV Cure Enters Phase 1 Clinical Trials via American Gene Technologies AGT103-T · BioBuzz](https://biobuzz.io/wp-content/uploads/2021/05/HIV-CURE.jpeg)
First Participant Infused with Potential HIV Cure Enters Phase 1 Clinical Trials via American Gene Technologies AGT103-T · BioBuzz
![HIV/AIDS Clinical Trials Network to Take on New Research Priorities Under Severe Funding Constraints HIV/AIDS Clinical Trials Network to Take on New Research Priorities Under Severe Funding Constraints](https://images.ctfassets.net/pdtztwrkphaf/tbart_tb_61247_body_0_image/3088fede3ed01fa29444d7b400f9acd6/NetworkDiagram.jpg?w=448&fm=jpg&fit=thumb&q=65&fl=progressive)
HIV/AIDS Clinical Trials Network to Take on New Research Priorities Under Severe Funding Constraints
![Guide for HIV/AIDS Clinical Care | National Prevention Information Network | Connecting public health professionals with trusted information and each other Guide for HIV/AIDS Clinical Care | National Prevention Information Network | Connecting public health professionals with trusted information and each other](https://npin.cdc.gov/sites/default/files/images/publications/008db9ca9ed80fa3687241fac98d178b.jpeg)
Guide for HIV/AIDS Clinical Care | National Prevention Information Network | Connecting public health professionals with trusted information and each other
![Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study - The Lancet HIV Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study - The Lancet HIV](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/34373d21-908b-4d08-82c5-fd0242aad44d/gr1.gif)
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study - The Lancet HIV
![Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure: Molecular Therapy - Methods & Clinical Development Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/asset/823a987d-8716-49aa-93b5-c537edbcd076/fx1.jpg)